The Daily PulseBusiness
Dr. Reddy's Reports Fall in Q2 Profit and Revenue
Reported by Aditya Chauhan (Staff Writer) · Economic Times - Markets ·
Reported by one source so far
Photo: Wikimedia CommonsDr. Reddy's Laboratories reported a 36 percent drop in its profit after tax for the second quarter of financial year 2027, coming in at ₹925 crore compared to ₹1,437 crore in the previous year. Revenue for the same period fell by 1.5 percent to ₹8,671 crore. Despite the downturn in financial numbers, the company expressed support for new trade margin regulations intended to improve patient access to important medicines. Management stated its commitment to improving core business performance and exploring new ways to grow.
Context
Trade margin regulations in the pharmaceutical sector are designed to control the markups on medicines and make healthcare more affordable for the public. Companies regularly review their quarterly earnings to adjust business strategies and manage market expectations.
More in Business
BusinessUnconfirmed — Reported by one source so farImportant
Sydney independent restaurants face severe financial strain amid rising costs and changing policies.
Reported by Deepak Mishra (Copy Editor) · ABC News Australia - Business ·
BusinessUnconfirmed — Reported by one source so farImportant
MK Sons Fine Jewels sets IPO price band at 153 to 162 rupees to raise 275 crore.
Reported by Neha Sharma (Staff Writer) · Livemint - Markets ·
